Dermatopathologist Services

This is a sole source announcement. A written solicitation will not be issued. Health Resources and Services Administration (HRSA) intends to award a firm fixed price contract to Dr. Mara Dasco Bracha to procure Dermatopathologist Services for Hansen's Disease (HD) patients. This service will include education, evaluation, treatment, and pathology services in relation to the diagnosis and exclusion of HD. The period of performance shall be for one 12-month base period. This effort is in support of the National Hansen's Disease Programs (NHDP).

This notice is provided pursuant to 40 U.S.C. 3304(a)(1) and FAR part 6.302-1: the supplies or services required by the agency are available from only one responsible source and no other type of supplies or services will satisfy agency requirements. Extensive market research was conducted prior to the posting of this notice. The proposed contractor has over one year experience of reading and diagnosing HD. Improper reading of can create false-positive readings which can impact the patient's life both physically and emotionally. Having this specialized experience in identifying HD will prevent this from occurring and allows for the pathologist to discern if the Mycobacterium leprae is present.
The intent of this notice is not to solicit competitive offers. The proposed contract action is for supplies and services for which the Government intends to solicit and negotiate with only one source under authority of FAR 6.302. Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive proposals. However, interested offerors may submit their capabilities or responses before the closing date and time of this notice to the Government for consideration.

A determination by the Government not to compete this proposed contract action is based upon responses to this notice and is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

No reimbursement will be made for any costs associated with providing information in response to this synopsis or any follow up information requests.

.